Jeffrey Ryan Stewart, Executive Vice President and Chief Commercial Officer at AbbVie Inc. (ABBV), recently sold a significant number of shares. On November 9, 2026, Stewart disposed of 40,619 shares of ABBV common stock at an average price of $293.60 per share.
The transaction amounted to approximately $11.93 million. This sale represents a notable divestment by a high-ranking executive within the pharmaceutical company.
Insider selling activity can be attributed to a variety of personal financial decisions, such as portfolio diversification or tax planning, and does not inherently signal a negative view of the company's future prospects.